JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB186745

Anti-Bok 抗体 [EPR15331]

Anti-Bok antibody [EPR15331]

Be the first to review this product! Submit a review

|

(13 Publications)

Rabbit Recombinant Monoclonal BOK antibody. Suitable for IP, WB and reacts with Human, Rat samples. Cited in 13 publications.

別名を表示する

BCL2L9, BOK, Bcl-2-related ovarian killer protein, hBOK, Bcl-2-like protein 9, Bcl2-L-9

4 Images
Immunoprecipitation - Anti-Bok antibody [EPR15331] (AB186745)
  • IP

Supplier Data

Immunoprecipitation - Anti-Bok antibody [EPR15331] (AB186745)

Western blot analysis of Bok in PC-3 cell lysate immunoprecipitated with ab186745 at 1/50 dilution (Lane1). Lane 2 : PBS instead of PC-3 cell lysate.

Secondary antibody : Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 dilution.

All lanes:

Immunoprecipitation - Anti-Bok antibody [EPR15331] (ab186745)

Predicted band size: 23 kDa

false

Western blot - Anti-Bok antibody [EPR15331] (AB186745)
  • WB

Supplier Data

Western blot - Anti-Bok antibody [EPR15331] (AB186745)

All lanes:

Western blot - Anti-Bok antibody [EPR15331] (ab186745) at 1/1000 dilution

Lane 1:

Human fetal brain lysate at 10 µg

Lane 2:

Human fetal kidney lysate at 10 µg

Lane 3:

Human ovary cancer lysate at 10 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

Western blot - Anti-Bok antibody [EPR15331] (AB186745)
  • WB

Supplier Data

Western blot - Anti-Bok antibody [EPR15331] (AB186745)

All lanes:

Western blot - Anti-Bok antibody [EPR15331] (ab186745) at 1/1000 dilution

All lanes:

Rat spleen lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

Western blot - Anti-Bok antibody [EPR15331] (AB186745)
  • WB

Supplier Data

Western blot - Anti-Bok antibody [EPR15331] (AB186745)

All lanes:

Western blot - Anti-Bok antibody [EPR15331] (ab186745) at 1/1000 dilution

Lane 1:

HeLa cell lysate at 10 µg

Lane 2:

PC-3 cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-Bok antibody [EPR15331] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR15331

アイソタイプ

IgG

キャリアフリー

No

交差種

Rat, Human

アプリケーション

WB, IP

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30 - 1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

BCL2-related ovarian killer (Bok) is a pro-apoptotic member of the Bcl-2 protein family contributing to apoptosis regulation. Bok sometimes referred to by its weight as approximately 23-25 kDa facilitates programmed cell death through mitochondrial pathways. Researchers have identified its expression primarily in reproductive tissues like ovaries and testis with some presence in the liver. Bok interacts with other Bcl-2 family proteins which act as apoptosis regulators creating a balance between cell survival and death.
Biological function summary

Bok plays an important role in the intrinsic apoptosis pathway by modulating mitochondrial outer membrane permeabilization. Bok forms protein complexes with other Bcl-2 family members like Bax and Bak contributing to cytochrome c release. This release is important for the activation of caspases leading to cellular apoptosis. Bok also exercises a regulatory role on calcium homeostasis within cells although its exact mechanisms remain under study.

Pathways

Bok integrates into the mitochondrial apoptosis pathway and the endoplasmic reticulum stress response influencing cellular fate decisions. Within these pathways Bok interacts with proteins such as Bax Bak and Bcl-2 balancing pro-apoptotic and anti-apoptotic signals. Bok's ability to influence these pathways demonstrates its importance in maintaining cellular homeostasis and response to stress signals.

Bok has been associated with cancer and neurodegenerative diseases. Its role in promoting apoptosis links it to conditions where apoptosis is dysregulated such as tumorigenesis where reduced Bok activity could contribute to cancer progression. In neurodegenerative disorders like Alzheimer's Bok's interaction with proteins like Bax may exacerbate neuronal loss through increased apoptosis emphasizing the need for understanding Bok in developing therapeutic strategies.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Isoform 1. Apoptosis regulator that functions through different apoptotic signaling pathways (PubMed : 15102863, PubMed : 20673843, PubMed : 27076518). Plays a roles as pro-apoptotic protein that positively regulates intrinsic apoptotic process in a BAX- and BAK1-dependent manner or in a BAX- and BAK1-independent manner (PubMed : 15102863, PubMed : 27076518). In response to endoplasmic reticulum stress promotes mitochondrial apoptosis through downstream BAX/BAK1 activation and positive regulation of PERK-mediated unfolded protein response (By similarity). Activates apoptosis independently of heterodimerization with survival-promoting BCL2 and BCL2L1 through induction of mitochondrial outer membrane permeabilization, in a BAX- and BAK1-independent manner, in response to inhibition of ERAD-proteasome degradation system, resulting in cytochrome c release (PubMed : 27076518). In response to DNA damage, mediates intrinsic apoptotic process in a TP53-dependent manner (PubMed : 15102863). Plays a role in granulosa cell apoptosis by CASP3 activation (PubMed : 20673843). Plays a roles as anti-apoptotic protein during neuronal apoptotic process, by negatively regulating poly ADP-ribose polymerase-dependent cell death through regulation of neuronal calcium homeostasis and mitochondrial bioenergetics in response to NMDA excitation (By similarity). In addition to its role in apoptosis, may regulate trophoblast cell proliferation during the early stages of placental development, by acting on G1/S transition through regulation of CCNE1 expression (PubMed : 19942931). May also play a role as an inducer of autophagy by disrupting interaction between MCL1 and BECN1 (PubMed : 24113155).. Isoform 2. Pro-apoptotic molecule exerting its function through the mitochondrial pathway.
See full target information BOK

文献 (13)

Recent publications for all applications. Explore the full list and refine your search

Cells 14: PubMed39996719

2025

BCL-B Promotes Lung Cancer Invasiveness by Direct Inhibition of BOK.

Applications

Unspecified application

Species

Unspecified reactive species

Palaniappan Ramesh,Amal R Al Kadi,Gaurav M Borse,Maximilian Webendörfer,Gregor Zaun,Martin Metzenmacher,Fabian Doerr,Servet Bölükbas,Balazs Hegedüs,Smiths S Lueong,Joelle Magne,Beiyun Liu,Greisly Nunez,Martin Schuler,Douglas R Green,Halime Kalkavan

Zoological research 46:263-276 PubMed39973136

2025

Ribosome-associated pathological TDP-43 alters the expression of multiple mRNAs in the monkey brain.

Applications

Unspecified application

Species

Unspecified reactive species

Fu-Yu Deng,Gao-Lu Zhu,Kai-Li Ou,Long-Hong Zhu,Qing-Qing Jia,Xiang Wang,Ming-Wei Guo,Bang Li,Shi-Hua Li,Xiao-Jiang Li,Peng Yin

EMBO reports 25:3896-3924 PubMed39048751

2024

BCL-2 and BOK regulate apoptosis by interaction of their C-terminal transmembrane domains.

Applications

Unspecified application

Species

Unspecified reactive species

Tobias B Beigl,Alexander Paul,Thomas P Fellmeth,Dang Nguyen,Lynn Barber,Sandra Weller,Benjamin Schäfer,Bernhard F Gillissen,Walter E Aulitzky,Hans-Georg Kopp,Markus Rehm,David W Andrews,Kristyna Pluhackova,Frank Essmann

Pharmacological research 187:106628 PubMed36566002

2022

Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Alejandra Estepa-Fernández,Alba García-Fernández,Araceli Lérida-Viso,Juan F Blandez,Irene Galiana,Félix Sancenon-Galarza,Mar Orzáez,Ramón Martínez-Máñez

Cell 185:3356-3374.e22 PubMed36055199

2022

Sublethal cytochrome c release generates drug-tolerant persister cells.

Applications

Unspecified application

Species

Unspecified reactive species

Halime Kalkavan,Mark J Chen,Jeremy C Crawford,Giovanni Quarato,Patrick Fitzgerald,Stephen W G Tait,Colin R Goding,Douglas R Green

Pharmacological research 183:106356 PubMed35843569

2022

Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Araceli Lérida-Viso,Alejandra Estepa-Fernández,Ángela Morellá-Aucejo,Beatriz Lozano-Torres,María Alfonso,Juan F Blandez,Viviana Bisbal,Pilar Sepúlveda,Alba García-Fernández,Mar Orzáez,Ramón Martínez-Máñez

The Journal of pharmacy and pharmacology 73:145-151 PubMed33793805

2021

Sildenafil improves right ventricular remodelling in monocrotaline-induced rats by decreasing myocardial apoptosis and activating peroxisome proliferator-activated receptors.

Applications

Unspecified application

Species

Unspecified reactive species

Ye-Li Li,Yi-Qi Li,Fan-Qun Zeng,Xiao-Ying Lin,Xiao-Tong Li,Xing-Qiao Ren,Dan-Li Yang

Cell reports 34:108827 PubMed33691099

2021

BOK controls apoptosis by Ca transfer through ER-mitochondrial contact sites.

Applications

Unspecified application

Species

Unspecified reactive species

Marcos A Carpio,Robert E Means,Allison L Brill,Alva Sainz,Barbara E Ehrlich,Samuel G Katz

Cell death & disease 11:701 PubMed32839432

2020

The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA.

Applications

Unspecified application

Species

Unspecified reactive species

Alina Muenchow,Sandra Weller,Clemens Hinterleitner,Elke Malenke,Stefanie Bugl,Stefan Wirths,Martin R Müller,Klaus Schulze-Osthoff,Walter E Aulitzky,Hans-Georg Kopp,Frank Essmann

Digestion 101:794-806 PubMed31563901

2019

MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Okazaki,Toshihito Tanahashi,Yasushi Sato,Jinsei Miyoshi,Tadahiko Nakagawa,Tetsuo Kimura,Hiroshi Miyamoto,Yasuteru Fujino,Fumika Nakamura,Masanori Takehara,Beibei Ma,Masahiro Bando,Shinji Kitamura,Koichi Okamoto,Naoki Muguruma,Masahiro Sogabe,Tetsuji Takayama
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com